Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SGX:E5H
SGX:E5HFood

Golden Agri-Resources (SGX:E5H) Valuation After Q1 2026 Profit Surge On Lower Net Sales

Golden Agri-Resources (SGX:E5H) drew fresh attention after reporting first quarter 2026 results, with gross profit improving and operating profit nearly tripling, even though net sales were lower over the period. See our latest analysis for Golden Agri-Resources. The recent first quarter profit improvement appears to have coincided with rising enthusiasm in the stock. The share price is at SGD0.325 and a 90 day share price return of 14.04% supports a 1 year total shareholder return of...
NYSE:NSP
NYSE:NSPProfessional Services

Insperity (NSP) Is Down 12.2% After Issuing Cautious 2026 Guidance With Potential Q2 Loss

In the past quarter, Insperity reported Q1 2026 revenue of about US$1.90 billion with net income dropping to US$33 million, while issuing cautious guidance that includes the possibility of a loss in Q2 and a wide earnings range for the full year. Beneath the headline beat on adjusted earnings, the combination of weaker year-on-year profitability, lower worksite employee counts, and trimmed 2026 guidance highlighted ongoing margin pressures despite early progress on its multi-year recovery...
NYSE:RNR
NYSE:RNRInsurance

Surging EPS And Buybacks Could Be A Game Changer For RenaissanceRe Holdings (RNR)

RenaissanceRe Holdings Ltd. recently reported first-quarter 2026 results, with revenue of US$2,194.92 million and net income of US$293.38 million, alongside basic earnings per share from continuing operations of US$6.60. Despite lower revenue than a year earlier, the company more than lifted earnings per share and completed a US$667.59 million buyback covering 5.24% of its shares, highlighting how profitability and capital returns have shifted its financial profile. With first-quarter...
NYSE:ABG
NYSE:ABGSpecialty Retail

How Asbury’s Rising EPS and Aggressive Buybacks Will Impact Asbury Automotive Group (ABG) Investors

In late April 2026, Asbury Automotive Group reported first-quarter revenue of US$4.11 billion, slightly below the prior year, while net income rose to US$187.8 million and diluted earnings per share from continuing operations climbed to US$9.87. Over the same period, Asbury repurchased 678,000 shares for US$147 million, completing a US$477.27 million program that retired 2,187,090 shares, indicating a strong focus on enhancing per-share metrics alongside profitability. With earnings per...
NYSE:CR
NYSE:CRMachinery

Crane (CR) Is Down 6.7% After Raising 2026 EPS Guidance And Highlighting M&A Firepower – What's Changed

In late April 2026, Crane Company reported first-quarter sales of US$696.4 million, up from US$557.6 million a year earlier, raised its full-year 2026 EPS guidance, affirmed its US$0.255 quarterly dividend, and highlighted continued balance-sheet capacity for further acquisitions. The combination of recent sensing and process-flow acquisitions, ongoing M&A appetite at pro forma net leverage of 1.4x, and management’s confidence in both acquired and core operations marks a significant step in...
ENXTAM:TWEKA
ENXTAM:TWEKAElectrical

A Look At TKH Group (ENXTAM:TWEKA) Valuation After Results, Cable Delays And Automation Shift

TKH Group (ENXTAM:TWEKA) has just reported full year 2025 adjusted EBITA in line with expectations, while flagging production delays at its Eemshaven subsea cable facility and a weak first quarter outlook. See our latest analysis for TKH Group. The recent news on production delays and the planned exit from part of the cable activities comes against a backdrop of firm momentum, with a 30-day share price return of 18.03% and a 1-year total shareholder return of 26.82%. This suggests investors...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

OceanFirst Financial (OCFC) Valuation Check After First Quarter Earnings And Loan Charge Off Update

OceanFirst Financial (OCFC) drew fresh attention after reporting first quarter 2026 results, with net interest income of US$96.45 million, net income of US$20.51 million, and modestly higher loan charge-offs compared with the prior year period. See our latest analysis for OceanFirst Financial. Despite the first quarter results and slightly higher loan charge offs, the recent 1 day share price return of 3.21% decline and softer 7 day and 90 day share price returns contrast with a stronger 1...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Is Down 6.4% After Takeda Exits DNL593 Partnership - What's Changed

In early May 2026, Denali Therapeutics announced that partner Takeda will terminate their collaboration on DNL593 for strategic reasons unrelated to efficacy or safety, returning full development and commercialization rights to Denali. This shift gives Denali complete control over DNL593 and its underlying TransportVehicle technology, which it expects to further highlight with planned phase I/II data by the end of 2026. We will now examine how Denali regaining full rights to DNL593 could...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

How Investors Are Reacting To Bilibili (BILI) Analyst Upgrades On New Game Pipeline Optimism

Morgan Stanley recently upgraded Bilibili Inc. to Overweight, highlighting optimism about its upcoming game pipeline, including Romance of the Three Kingdoms: Wangdaotianxia, and potential game revenue growth in the years ahead. This shift in analyst sentiment, echoed by Goldman Sachs’ positive view on advertising prospects and game launches, suggests growing confidence in Bilibili’s efforts to deepen monetization across its entertainment ecosystem. We’ll now consider how optimism around...
SEHK:6082
SEHK:6082Semiconductor

Asian Growth Stocks With Up To 33% Insider Ownership

As Asia's markets navigate a landscape marked by geopolitical tensions and economic resilience, investors are increasingly looking towards growth companies with substantial insider ownership as potential opportunities. In this context, stocks with high insider stakes can offer insights into management confidence and alignment of interests, making them particularly appealing amidst the region's evolving economic conditions.
SEHK:9982
SEHK:9982Real Estate

Asian Penny Stocks To Watch In May 2026

As global markets navigate the complexities of central bank policies and geopolitical tensions, Asia's financial landscape remains a focal point for investors seeking growth opportunities. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid fundamentals. Despite being a somewhat outdated term, these stocks offer intriguing prospects for those looking to uncover hidden value in the...
ASX:DRR
ASX:DRRMetals and Mining

A Look At Deterra Royalties (ASX:DRR) Valuation After March Quarter Update And Thacker Pass Progress

March quarter update and why it matters for Deterra Royalties (ASX:DRR) Deterra Royalties (ASX:DRR) drew investor attention after reporting steady March quarter revenue, supported by cash flows from Mining Area C royalties despite softer iron ore prices, alongside progress at the Thacker Pass lithium project. See our latest analysis for Deterra Royalties. Over the past year, Deterra Royalties has combined a 2.9% year to date share price return with a 23.2% total shareholder return, suggesting...
NYSE:ENVA
NYSE:ENVAConsumer Finance

A Look At Enova International’s (ENVA) Valuation After Strong Q1 Results And Raised 2026 Outlook

Enova International (ENVA) has drawn investor attention after its latest Q1 update, which combined higher revenue and earnings with record small business originations, a raised 2026 outlook, and ongoing work on a Grasshopper Bank funding partnership. See our latest analysis for Enova International. The stock has cooled in the past week, with a 1-day share price return of -4.11% and 7-day share price return of -5.58%, after a strong 30-day share price return of 19.75% and a very large 5-year...
ASX:VUL
ASX:VULMetals and Mining

A Look At Vulcan Energy Resources (ASX:VUL) Valuation As Lionheart Construction Progresses

Vulcan Energy Resources (ASX:VUL) is back in focus after confirming that full scale construction has started at its central lithium chemical plant in Frankfurt, following the completion of funding, the receipt of approvals, and a positive Lionheart investment decision. See our latest analysis for Vulcan Energy Resources. Recent price action has been mixed, with a 15.6% 1 month share price return contrasting with a 13.9% year to date share price decline and a 42.7% 5 year total shareholder...
SWX:IDIA
SWX:IDIABiotechs

Idorsia (SWX:IDIA) Valuation Check After QUVIVIQ Guidance And First Quarter 2026 Update

What Idorsia’s new QUVIVIQ guidance tells you Idorsia (SWX:IDIA) has put QUVIVIQ at the center of its 2026 outlook, guiding for CHF 200 million in sales after releasing its first quarter results and updating progress on its broader pipeline and partnerships. See our latest analysis for Idorsia. Following the first quarter update and QUVIVIQ guidance, Idorsia’s recent share price moves look mixed, with a 30 day share price return of 8.16% but a year to date share price return of a 6.35%...
NYSE:QTWO
NYSE:QTWOSoftware

Q2 Holdings (QTWO) Is Up 5.5% After Raising 2026 Guidance And Unveiling New AI Fraud Tools

In late April 2026, Q2 Holdings reported first-quarter revenue of US$216.51 million and net income of US$26.64 million, while guiding second-quarter 2026 revenue to US$214.0–US$218.0 million and full-year 2026 revenue to US$875.0–US$882.0 million, alongside launching new AI-driven fraud prevention and treasury onboarding solutions. The combination of double-digit year-over-year revenue growth, record bookings, expanding profitability, and embedded AI products in digital banking and fraud...
TSE:5201
TSE:5201Building

A Look At AGC (TSE:5201) Valuation After New Biologics Agreement And Yokohama Facility Plans

AGC stock in focus after expanded biologics agreement AGC (TSE:5201) has come into focus after AGC Biologics expanded its manufacturing agreement with Novelty Nobility and advanced plans for a new large scale biologics facility in Yokohama, Japan. The latest agreement extends work on a bispecific antibody drug candidate, progressing from successful cell line development in Copenhagen to process development and GMP manufacturing in Chiba, supported by AGC Biologics’ integrated global...